Ameriprise Financial, Inc. · AMP · FY2025 Q1 · Calendar Q2 2025
Ameriprise emphasizes wealth flows and product expansion
The analysis supports a constructive but qualified view: strong wealth-management flows, product innovation, adviser productivity, and technology investment provide growth support, while asset-management outflows and rate-sensitive net interest income could limit durability.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about AMP FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter's analysis highlighted continued wealth-management momentum, a broader product rollout agenda, and added bank offerings. It also identified asset-management outflows and rate sensitivity as the main counterweights; guidance sentiment remained maintained.
Guidance delta
Management guidance sentiment was maintained; no new quantitative guidance is supplied in the analysis.
Key takeaways
- Management described strong wealth-management client flows and wrap-product growth as key drivers.
- Signature Wealth UMA, active ETFs, SMA delivery, and bank products are central product initiatives.
- Capital returns remain a priority, alongside technology investment and adviser productivity.
- Asset-management outflows and rate-sensitive bank income remain important risks to monitor.
Management priorities
- Broaden Signature Wealth UMA
- Expand active ETFs and SMA model delivery
- Add bank products including CDs, HELOCs, and checking accounts
- Improve client engagement and operating efficiency through technology
- Maintain capital-return flexibility
Follow AMP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Underweight | Underweight | Maintain | Oct 9, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 7, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 6, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 24, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 25, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 25, 2025 |
| UBS | Neutral | Buy | Downgrade | Jan 6, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 27, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 1, 2023 |
| B of A Securities | Buy | Buy | Maintain | Sep 7, 2022 |
| Citigroup | Buy | Buy | Maintain | Jun 21, 2021 |
| Barclays | Overweight | Overweight | Maintain | Apr 12, 2021 |
| CFRA | Buy | Buy | Maintain | May 13, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 26, 2017 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 14, 2016 |
| Wells Fargo | Market Perform | Outperform | Downgrade | Jan 13, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 13, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $502.58. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $483 | $499.08 | -3.9% | Oct 9, 2026 |
| Capital One Financial | Brennan Hawken | $520 | $496.67 | +3.5% | Oct 6, 2026 |
| Raymond James | Analyst unavailable | $570 | $490.91 | +13.4% | Oct 5, 2026 |
| Raymond James | Analyst unavailable | $638 | $558.26 | +26.9% | Aug 21, 2026 |
| Piper Sandler | Analyst unavailable | $518 | $506.76 | +3.1% | Jul 13, 2026 |
| Morgan Stanley | Michael Cyprys | $489 | $506.62 | -2.7% | Jul 10, 2026 |
| Jefferies | Suneet Kamath | $645 | $500.16 | +28.3% | Jul 10, 2026 |
| Piper Sandler | Crispin Love | $471 | $467.19 | -6.3% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $467 | $479.63 | -7.1% | Apr 30, 2026 |
| BMO Capital | Brennan Hawken | $490 | $455.71 | -2.5% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $560 | $456.59 | +11.4% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $452 | $441.86 | -10.1% | Apr 10, 2026 |
| Raymond James | Wilma Burdis | $582 | $488.19 | +15.8% | Feb 11, 2026 |
| RBC Capital | Kenneth Lee | $605 | $529.47 | +20.4% | Feb 2, 2026 |
| Piper Sandler | John Barnidge | $530 | $521.36 | +5.5% | Jan 29, 2026 |
| Morgan Stanley | Analyst unavailable | $485 | $489.17 | -3.5% | Dec 22, 2025 |
| Evercore ISI | Analyst unavailable | $570 | $490.17 | +13.4% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $484 | $486.62 | -3.7% | Oct 1, 2025 |
| Morgan Stanley | Michael Cyprys | $462 | $519.55 | -8.1% | May 15, 2025 |
| Morgan Stanley | Michael Cyprys | $509 | $514.04 | +1.3% | Oct 30, 2024 |
| Goldman Sachs | Alexander Blostein | $476 | $463.09 | -5.3% | Sep 25, 2024 |
| RBC Capital | Kenneth Lee | $500 | $432.05 | -0.5% | Jul 30, 2024 |
| UBS | Brennan Hawken | $495 | $429.25 | -1.5% | Jul 9, 2024 |
| Argus Research | Kevin Heal | $460 | $418.95 | -8.5% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $445 | $412.86 | -11.5% | Apr 24, 2024 |
| Morgan Stanley | Michael Cyprys | $437 | $435.77 | -13.0% | Apr 9, 2024 |
| Piper Sandler | John Barnidge | $392 | $428.89 | -22.0% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $345 | $320.45 | -31.4% | Jan 10, 2023 |
| UBS | Analyst unavailable | $370 | $324.71 | -26.4% | Jan 9, 2023 |
| Goldman Sachs | Analyst unavailable | $330 | $332.97 | -34.3% | Nov 23, 2022 |
| Morgan Stanley | Analyst unavailable | $340 | $316.94 | -32.3% | Nov 17, 2022 |
| Piper Sandler | Analyst unavailable | $220 | $223.12 | -56.2% | Jul 15, 2022 |
| Piper Sandler | Analyst unavailable | $231 | $238.27 | -54.0% | Jul 8, 2022 |
| Piper Sandler | John Barnidge | $253 | $235.1 | -49.7% | Jun 21, 2022 |
| Piper Sandler | Analyst unavailable | $275 | $274.33 | -45.3% | May 27, 2022 |
| UBS | Analyst unavailable | $350 | $267.4 | -30.4% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $330 | $280.96 | -34.3% | Apr 26, 2022 |
| Jefferies | Suneet Kamath | $350 | $293.04 | -30.4% | Apr 9, 2022 |
| Piper Sandler | John Barnidge | $310 | $292.26 | -38.3% | Apr 6, 2022 |
Track every rating change on AMP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAmeriprise Financial, Inc. is a holding company, which engages in providing financial planning, asset management, and insurance services to individuals, businesses, and institutions. It operates through the following business segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment consists of financial planning and advice, as well as full-service brokerage services for retail clients through financial advisors.…
Historical context
All AMP earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| USB-PR U.S. Bancorp | FY2026 Q3 · Calendar Q4 2026 | +1.5% | — | U.S. Bancorp lifts guidance as fee growth and BTIG support Q3 |
| USB-PS U.S. Bancorp Depositary Shares, | FY2026 Q3 · Calendar Q4 2026 | +1.5% | — | U.S. Bancorp Q3: Record Revenue, Higher Full-Year Guidance |
| FHN First Horizon Corporation | FY2026 Q3 · Calendar Q4 2026 | +1.1% | +0.8% | First Horizon: Mortgage sale reshapes margin and capital outlook |
| USB-PQ U.S. Bancorp | FY2026 Q3 · Calendar Q4 2026 | +1.5% | — | U.S. Bancorp Q3: Fee growth and raised guidance lead the story |
| PNC The PNC Financial Services Group, Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.7% | -0.4% | PNC raises full-year outlook as growth offsets margin pressure |
| USB-PA U.S. Bancorp PERP PFD SER A | FY2026 Q3 · Calendar Q4 2026 | +1.5% | — | U.S. Bancorp Q3: Fee Growth and BTIG Lift Guidance |
Latest beats and misses
Who reports nextBeat on EPS
Get the AMP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-12T07:15:41.793903+00:00
- Polygon adjusted daily market bars · 2026-10-16T12:20:41.665461+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T12:20:41.662599+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.